It is remarkable that, in addition to FLG gene mutations, type 2 inflammatory mediators, as well as inflammation mediated by Th17, Th22 and Th1, can also reduce FLG expression, as reported in humans with AD.16 The gene discussed is FLG; the disease is Alzheimer disease.